Publications

5674 Results

Erectile dysfunction and subsequent cardiovascular disease

Authors
IM Thompson;CM Tangen;P Goodman;JL Probstfield;CM Moinpour;CA Coltman
Journal / Conference
JAMA 294(23):2996-3002
Year
2005
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Phase III randomized study of adjuvant radiation therapy versus observation in patients with pathologic T3 prostate cancer (SWOG 8794)

Authors
G Swanson;I Thompson;C Tangen;G Miller;MS Lucia;D Troyer;J Paradelo;J Chin;E Messing;E Canby-Hagino;J Forman;ED Crawford
Journal / Conference
Proc ASTRO, Int J Radiat Oncol Biol Phy 63 (Suppl 1):S1 (#1), 2005.
Year
2005
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8794

Mantle cell lymphoma: at last, some hope for successful innovative treatment strategies

Authors
RI Fisher
Journal / Conference
Journal of Clinical Oncology 23(4):657-658
Year
2005
Research Committee(s)
Lymphoma

Behavior and cancer prevention

Authors
CC Gotay
Journal / Conference
Journal of Clinical Oncology 23(2):301-310
Year
2005
Research Committee(s)
Cancer Control

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

Authors
S Bea;A Zettl;G Wright;I Salaverria;P Jehn;V Moreno;C Burek;G Ott;X Puig;L Yang;A Lopez-Guillermo;WC Chan;TC Greiner;DD Weisenburger;JO Armitage;RD Gascoyne;JM Connors;TM Grogan;R Braziel;RI Fisher;EB Smeland;S Kvaloy;H Holte;J Delabie;R Simon;J Powell;WH Wilson;ES Jaffe;E Montserrat;HK Muller Hermelink;LM Staudt;E Campo;A Rosenwald
Journal / Conference
Blood 106(9):3183-3190
Year
2005
Research Committee(s)
Lymphoma

Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089

Authors
DG Haller;PJ Catalano;JS Macdonald;MA O'Rourke;MS Frontiera;DV Jackson;RJ Mayer
Journal / Conference
Journal of Clinical Oncology 23(34):8671-8678
Year
2005
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8899 (INT-0089)

High incidence of thrombotic events observed in patients receiving lenalidomide (L) + dexamethasone (D) (LD) as first-line therapy for multiple myeloma (MM) without aspirin (ASA) prophylaxis

Authors
JA Zonder;BGM Durie;J McCoy;J Crowley;JB Zeldis;L Ghannam;B Barlogie
Journal / Conference
Blood (ASH Annual Meeting Abstracts) 106(11): #3455
Year
2005
Research Committee(s)
Myeloma
Study Number(s)
S0232

International staging system for multiple myeloma

Authors
PR Greipp;J San Miguel;BGM Durie;JJ Crowley;B Barlogie;J Blade;M Boccadoro;JA Child;H Avet-Loiseau;RA Kyle;JJ Lahuerta;H Ludwig;G Morgan;R Powles;K Shimizu;C Shustik;P Sonneveld;P Tosi;I Turesson;J Westin
Journal / Conference
Journal of Clinical Oncology 23(15):3412-3420
Year
2005
Research Committee(s)
Myeloma
PMID
PMID15809451

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

Authors
EH Romond;EA Perez;J Bryant;VJ Suman;CE Geyer, Jr;NE Davidson;E Tan-Chiu;S Martino;S Paik;PA Kaufman;SM Swain;TM Pisansky;L Fehrenbacher;LA Kutteh;VG Vogel;DW Visscher;G Yothers;RB Jenkins;AM Brown;SR Dakhil;E Mamounas;WL Lingle;PM Klein;JN Ingle;N Wolmark
Journal / Conference
New England Journal of Medicine 353(16):1673-1684
Year
2005
Research Committee(s)
Breast
Study Number(s)
N9831

Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures

Authors
D Mahadevan;C Spier;K Della Croce;S Miller;B George;C Riley;S Warner;TM Grogan;TP Miller
Journal / Conference
Molecular Cancer Therapeutics 4(12):1867-1879
Year
2005
Research Committee(s)
Lymphoma
PMID
PMID16373702